ondasdechoque.org
PT-BR

Multiple tissues and imaging outcomes · Review · 2020

Can shockwave change what scans show, like shoulder calcium deposits?

In this review, shockwave cleared shoulder calcium deposits completely more often than placebo on scans, and thinned thickened heel tissue more than placebo. Needling the deposit under ultrasound cleared calcium more often than shockwave.

studies
63
studies combined in the analysis
27
areas pooled: shoulder calcium, heel tissue, hip bone
3

Good to know: Scans were the measure here; the review did not look at pain or function.

Al-Abbad H, Allen S, Morris S, et al. BMC Musculoskeletal Disorders, 2020 · Read the paper ↗

How this study worked

One answer
A review gathers earlier studies to answer one question. Illustration, not to scale.

What happened

Compared with
Placebo, needling under ultrasound, steroid injection, laser or ultrasound therapy, or other treatments

Shoulder calcium deposits fully cleared on scans

Odds ratio; above 1 means more full clearing with shockwave

Calcium deposits cleared completely more often with shockwave than with placebo, but less often than with needling under ultrasound.
Show the numbers
Odds ratiolikely range
Shockwave vs placebo6.381.33 to 30.7
Shockwave vs needling0.270.12 to 0.64

What the trials used

Scope
Focused and radial shockwave studies, varied comparators and imaging measures across shoulder calcification, plantar fascia/heel spur, femoral-head osteonecrosis and other conditions.
Dose summary
Across included studies, dose and device parameters varied; the review reports that dose parameters did not significantly explain imaging outcomes in subgroup/meta-regression analyses.

Who took part

Adults with shoulder calcium deposits, heel pain or heel spurs, hip bone damage (osteonecrosis) and other conditions, in 63 studies.

Side effects

This review looked at scans and did not report side effects.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

63 prospective reports of SWT for diverse musculoskeletal conditions; 27 contributed to quantitative synthesis. Clinical conditions and imaging outcomes were heterogeneous.

Rotator-cuff calcium deposit diameter1 reported outcome
01
As reported across included follow-up times

Rotator-cuff calcium deposit diameter

Rotator-cuff calcium deposit diameter mm

MD8.44CI 4.3 to 12.57p <0.001

Within-SWT pooled change in calcific deposit diameter

-1.5Equal results 014.1

Within-group pooled change after SWT across five studies; lower diameter favors reduction. Abstract’s interval conflicts with main text, so the main-text interval is recorded and the discrepancy flagged.

Analysis details and source

Imaging outcome is not a patient-reported pain or functional benefit. Review reports no evidence that protocol-dose subgroups explain the changes.

Total calcium resorption: SWT vs placebo1 reported outcome
02
As reported across included follow-up times

Total calcium resorption: SWT versus placebo

Total calcium resorption: SWT vs placebo odds ratio

OR6.38CI 1.33 to 30.7p = 0.02

SWT versus placebo

0.7Equal results 146.3

Logarithmic ratio scale.

Total calcium resorption was reported in 222/559 shoulders overall (printed as 35%, although 222/559 is 39.7%). SWT had higher odds of total resorption than placebo (OR 6.38, 95% CI 1.33–30.70; p=0.02). The 222/559 denominator is overall synthesis context, not an arm-specific denominator.

Analysis details and source

Imaging outcome is not a patient-reported pain or functional benefit. Review reports no evidence that protocol-dose subgroups explain the changes.

Total calcium resorption: SWT vs ultrasound-guided needling1 reported outcome
03
As reported across included follow-up times

Total calcium resorption: SWT vs ultrasound-guided needling

Total calcium resorption: SWT vs ultrasound-guided needling odds ratio

OR0.27CI 0.12 to 0.64p = 0.003

SWT versus ultrasound-guided needling

0.1Equal results 11.3

Logarithmic ratio scale.

Total calcium resorption was lower with SWT than ultrasound-guided needling (OR 0.27, 95% CI 0.12–0.64; p=0.003); this estimate favors the active needling comparator, not SWT.

Analysis details and source

Imaging outcome is not a patient-reported pain or functional benefit. Review reports no evidence that protocol-dose subgroups explain the changes.

Plantar fascia thickness4 reported outcomes
04
As reported across included follow-up times

Plantar fascia thickness

Plantar fascia thickness mm

MD0.92CI 0.03 to 1.81p = 0.04

Within-SWT pooled change in plantar fascia thickness

-0.2Equal results 02

Within-group pooled reduction after SWT; the abstract and main text report discrepant lower CI signs, and the main text gives +0.03.

Analysis details and source

Imaging outcome is not a patient-reported pain or functional benefit. Review reports no evidence that protocol-dose subgroups explain the changes.

09
Follow-up as reported in contributing studies

Plantar fascia thickness: SWT versus corticosteroid injection

Plantar fascia thickness mm

MD-0.3CI 95% -0.62 to 0.02p = 0.07

SWT versus corticosteroid injection

-0.7Equal results 00.1

The reported difference favored SWT versus corticosteroid injection but was not statistically significant (MD −0.30 mm, 95% CI −0.62 to 0.02; p=0.07).

Analysis details and source

The source reports comparator direction and estimate as printed; CI includes zero, so no clear between-treatment difference is established.

10
Follow-up as reported in contributing studies

Plantar fascia thickness: SWT versus placebo

Plantar fascia thickness mm

MD-0.9CI 95% -1.56 to -0.24p = 0.007

SWT versus placebo

1 study

-1.7Equal results 00.2

The source reports greater reduction in plantar fascia thickness with SWT than placebo (MD −0.90 mm, 95% CI −1.56 to −0.24; p=0.007).

Analysis details and source

Single-trial comparison (Vahdatpour [56]) within the review’s meta-analysis; direction and magnitude are retained as printed without deriving percentage change or a patient-reported clinical benefit.

11
Follow-up as reported in contributing studies

Plantar fascia thickness: SWT versus low-level laser therapy or therapeutic ultrasound

Plantar fascia thickness mm

MD0.43CI 95% 0.09 to 0.78p = 0.01

SWT versus low-level laser therapy and versus therapeutic ultrasound (separate comparator groups of one trial, combined in the review’s estimate)

1 study

-0.1Equal results 00.9

SWT had less effect on plantar fascia thickness than low-level laser therapy and therapeutic ultrasound (MD 0.43 mm, 95% CI 0.09 to 0.78; p=0.01), as reported. The estimate comes from one trial (Ulusoy [55]) in which laser therapy and therapeutic ultrasound were given to separate groups, not combined.

Analysis details and source

The source reports SWT as less effective, with a positive estimate for the stated comparison; preserve its direction/coding and do not reverse the sign.

Plantar fascia thickness by imaging guidance1 reported outcome
05
As reported across included follow-up times

Plantar fascia thickness by imaging guidance

Plantar fascia thickness by imaging guidance mm

MD1.31CI 0.49 to 2.13p = 0.002

SWT with radiological guidance, within-subgroup pooled change

-0.3Equal results 02.4

Subgroup with radiological guidance; subgroup without guidance was not significant (MD 0.47, 95% CI −0.28 to 1.21, p=.22).

Analysis details and source

Imaging outcome is not a patient-reported pain or functional benefit. Review reports no evidence that protocol-dose subgroups explain the changes.

Femoral-head osteonecrosis lesion size2 reported outcomes
06
6 months to 3 years, pooled across reported follow-ups

Femoral-head osteonecrosis lesion size

Femoral-head osteonecrosis lesion size %

MD4.84CI -0.06 to 9.75p = 0.05

Within-SWT pooled change in femoral-head osteonecrosis lesion size

-1.2Equal results 010.9

The article describes a modest reduction with borderline significance; the interval includes no change.

Analysis details and source

Imaging outcome is not a patient-reported pain or functional benefit. Review reports no evidence that protocol-dose subgroups explain the changes.

12
Follow-up as reported in contributing studies

Femoral-head osteonecrosis lesion size: SWT versus other interventions

Femoral-head osteonecrosis lesion size %

MD-8.5CI 95% -16.4 to -0.59p = 0.04

SWT versus other interventions (pooled comparison)

-18.4Equal results 02

The pooled lesion-size comparison generally favored SWT over other interventions (MD −8.50 percentage points, 95% CI −16.40 to −0.59; p=0.04). Included comparators varied.

Analysis details and source

The source pools multiple comparators. This is a review-reported between-intervention contrast, not a specific head-to-head protocol comparison.

Calcium deposit diameter2 reported outcomes
07
Follow-up as reported in contributing studies

Calcium deposit diameter: SWT versus placebo

Calcium deposit diameter mm

MD-11.26CI 95% -24.68 to 2.17p = 0.10

SWT versus placebo

-27.9Equal results 05.4

SWT showed a nonsignificant reduction in calcium-deposit size versus placebo (MD −11.26 mm, 95% CI −24.68 to 2.17; p=0.10). The confidence interval includes no difference.

Analysis details and source

A negative difference means smaller deposits with SWT than with placebo, as both the review’s wording (favoring SWT) and the Table 2 post-treatment means of the two contributing trials (Cacchio [21], Hsu [29]) show.

08
Follow-up as reported in contributing studies

Calcium deposit diameter: SWT versus ultrasound-guided needling

Calcium deposit diameter mm

MD4.25CI 95% 2.27 to 6.24p = 0.006

SWT versus ultrasound-guided needling

-0.7Equal results 07

The source states that the effect of SWT on calcium-deposit size was less than ultrasound-guided needling (MD 4.25 mm, 95% CI 2.27 to 6.24; p=0.006). The comparison direction is preserved as printed.

Analysis details and source

A positive difference means larger remaining deposits with SWT than with the comparator, consistent with the review calling SWT less effective (Table 2 post-treatment means: Del Castillo-Gonzalez [26], ultrasound-guided percutaneous lavage, 4.67 vs 1.56 mm; Kim [31], 5.6 vs 0.45 mm). The printed p = 0.006 does not fit the printed interval of 2.27 to 6.24, which corresponds to p < 0.001; both are kept as printed.

Meta-regression of imaging outcome3 reported outcomes
13
Across contributing study follow-ups

Baseline calcium-deposit size as predictor of SWT imaging change

Meta-regression of imaging outcome mm

Meta-regression coefficient1.38CI 95% 0.98 to 1.77p = 0.002

Baseline lesion size as moderator of SWT pooled imaging effect

-0.2Equal results 02

Baseline calcium-deposit size was the only significant moderator of the SWT imaging effect (coefficient 1.38; 95% CI 0.98–1.77; I²=43.55%; adjusted R²=99.18%; p=0.002). This is a meta-regression predictor, not a treatment effect.

Analysis details and source

These are study-level meta-regression associations reported by the review, not patient-level predictors or clinical treatment-effect estimates.

14
Across contributing study follow-ups

Baseline plantar fascia thickness as predictor of SWT imaging change

Meta-regression of imaging outcome mm

Meta-regression coefficient-1.06CI 95% -1.59 to -0.53p = 0.004

Baseline lesion size as moderator of SWT pooled imaging effect

-1.8Equal results 00.2

Baseline plantar fascia thickness predicted the SWT imaging effect (coefficient −1.06; 95% CI −1.59 to −0.53; I²=78%; adjusted R²=85.10%; p=0.004). This is a meta-regression predictor, not a treatment effect.

Analysis details and source

These are study-level meta-regression associations reported by the review, not patient-level predictors or clinical treatment-effect estimates.

15
Across contributing study follow-ups

Baseline lesion size as predictor of SWT imaging change

Meta-regression of imaging outcome %

Meta-regression coefficient0.87CI 95% 0.48 to 1.26p = 0.001

Baseline lesion size as moderator of SWT pooled imaging effect

-0.2Equal results 01.4

Baseline lesion size predicted the SWT imaging effect (coefficient 0.87; 95% CI 0.48–1.26; I²=6.2%; adjusted R²=93.77%; p=0.001). This is a meta-regression predictor, not a treatment effect.

Analysis details and source

These are study-level meta-regression associations reported by the review, not patient-level predictors or clinical treatment-effect estimates.

How treatment was delivered
Scope

Focused and radial shockwave studies, varied comparators and imaging measures across shoulder calcification, plantar fascia/heel spur, femoral-head osteonecrosis and other conditions.

Dose summary

Across included studies, dose and device parameters varied; the review reports that dose parameters did not significantly explain imaging outcomes in subgroup/meta-regression analyses.

HARMS & TOLERABILITY

The synthesis focused on imaging and reports no adverse-event data; unreported harms are not zero events.

LIMITS OF THE ANALYSIS

Authors report high risk of bias (mean scores 59.68% for 31 RCTs and 73.61% for non-RCTs; the review elsewhere counts 30 RCTs among its 63 studies) and incomplete standardization/reporting of imaging procedures. Few trials per condition prevented publication-bias testing and limited meta-regression.

The synthesis concerns structural imaging. Its results cannot be generalized across diagnoses or substituted for pain, function, recovery or surgery outcomes. The article itself reports ultrasound-guided needling outperforming SWT on calcific resorption.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Authors report high risk of bias (mean scores 59.68% for 31 RCTs and 73.61% for non-RCTs; the review elsewhere counts 30 RCTs among its 63 studies) and incomplete standardization/reporting of imaging procedures. Few trials per condition prevented publication-bias testing and limited meta-regression.
  • The synthesis concerns structural imaging. Its results cannot be generalized across diagnoses or substituted for pain, function, recovery or surgery outcomes. The article itself reports ultrasound-guided needling outperforming SWT on calcific resorption.
Research review

Source-linked critical reading

Systematic review with meta-analysis

Reading depthMaterial consulted
Technical source record

Complete article XML read, including Methods, all Results subsections and tables, figure captions, Discussion, Conclusion and disclosures.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Systematic review and meta-analysis of prospective studies, including 63 reports and quantitative synthesis of 27. Review spans multiple conditions; reports and populations should not be treated as a single cohort.

Participants

Adults with varied musculoskeletal conditions. Imaging outcomes included calcium deposits, plantar fascia thickness, femoral-head lesions and other structural measures.

Intervention

Focused and radial SWT protocols varied widely across studies; subgroup/meta-regression did not show dose parameters as significant explanations for imaging effects.

Comparator

Comparisons included placebo, ultrasound-guided needling, conservative or surgical treatments and within-group baseline change; interpret each synthesis separately.

Outcomes

Reported imaging estimates include calcium deposit diameter reduction (MD 8.44 mm, main-text CI 4.30–12.57, p<.001); plantar fascia thickness reduction (MD 0.92 mm, main-text CI 0.03–1.81, p=.04); and femoral-head lesion size change (MD 4.84%, CI −0.06–9.75, p=.05). Two abstract confidence limits conflict with the main text and are explicitly flagged in the records. Main-text comparisons also report calcium size: SWT vs placebo MD −11.26 mm (95% CI −24.68 to 2.17; p=0.10), and SWT vs ultrasound-guided needling MD 4.25 (2.27 to 6.24; p=0.006), with the latter described as favoring needling. For plantar thickness, source comparisons include SWT vs corticosteroid (−0.30 mm, −0.62 to 0.02; p=0.07), placebo (−0.90, −1.56 to −0.24; p=0.007), and low-level laser therapy or therapeutic ultrasound (0.43, 0.09 to 0.78; p=0.01; one trial with separate laser and ultrasound groups; described as favoring the comparators). For osteonecrosis, a pooled comparison versus other interventions was MD −8.50 percentage points (−16.40 to −0.59; p=0.04). Meta-regressions associated baseline lesion size with imaging effects for calcium (coefficient 1.38, 0.98–1.77; p=0.002), plantar fascia (−1.06, −1.59 to −0.53; p=0.004), and osteonecrosis (0.87, 0.48–1.26; p=0.001); these are study-level moderator associations, not treatment effects.

Between-group interpretation

SWT was favored over placebo for total calcium resorption (OR 6.38, 95% CI 1.33–30.70, p=.02), while ultrasound-guided needling was favored over SWT (OR 0.27, 95% CI 0.12–0.64, p=.003). Imaging changes do not establish symptom or functional benefit.

Harms

The article reports imaging outcomes; the extraction does not treat absent adverse-event details as zero harms.

Limitations

Authors report high risk of bias (mean scores 59.68% for 31 RCTs and 73.61% for non-RCTs; the review elsewhere counts 30 RCTs among its 63 studies) and incomplete standardization/reporting of imaging procedures. Few trials per condition prevented publication-bias testing and limited meta-regression.

Applicability

The synthesis concerns structural imaging. Its results cannot be generalized across diagnoses or substituted for pain, function, recovery or surgery outcomes. The article itself reports ultrasound-guided needling outperforming SWT on calcific resorption.

What a stronger study should do

Future trials should use standardized and reproducible imaging methods, blinded reliable assessors, prespecified timepoints and patient-important clinical endpoints alongside imaging, with adequate sample sizes.

THE ORIGINAL SOURCE

Read the original article.

The effects of shockwave therapy on musculoskeletal conditions based on changes in imaging: a systematic review and meta-analysis with meta-regression.

Al-Abbad H, Allen S, Morris S, Reznik J, Biros E, Paulik B, Wright A. · BMC musculoskeletal disorders · 2020

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →